Top Medical Stocks To Follow Today – June 16th

UnitedHealth Group, Hims & Hers Health, and Eli Lilly and Company are the three Medical stocks to watch today, according to MarketBeat’s stock screener tool. Medical stocks are shares of publicly traded companies operating in the healthcare sector, including pharmaceutical and biotechnology firms, medical device manufacturers, hospital networks, diagnostics providers and health‐care service companies. Investors buy and sell these stocks to gain exposure to the development, production and delivery of medical treatments and technologies. Because the industry is heavily regulated and driven by research outcomes, medical stocks often exhibit distinct risk and return patterns compared with other sectors. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Shares of NYSE UNH traded down $3.65 during trading on Monday, hitting $307.67. 8,522,151 shares of the company traded hands, compared to its average volume of 7,208,248. The business’s fifty day moving average is $386.66 and its 200 day moving average is $472.32. UnitedHealth Group has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm has a market capitalization of $279.10 billion, a price-to-earnings ratio of 19.87, a P/E/G ratio of 1.37 and a beta of 0.44.

Hims & Hers Health (HIMS)

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Shares of NYSE HIMS traded up $3.98 during midday trading on Monday, hitting $59.46. 29,985,254 shares of the stock traded hands, compared to its average volume of 21,193,330. Hims & Hers Health has a one year low of $13.47 and a one year high of $72.98. The business has a 50 day moving average price of $45.09 and a two-hundred day moving average price of $38.26. The company has a market cap of $13.31 billion, a PE ratio of 135.37 and a beta of 2.09.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Shares of Eli Lilly and Company stock traded down $5.27 during trading hours on Monday, reaching $814.09. The company’s stock had a trading volume of 1,398,636 shares, compared to its average volume of 3,649,628. Eli Lilly and Company has a one year low of $677.09 and a one year high of $972.53. The company has a market capitalization of $771.54 billion, a P/E ratio of 69.56, a P/E/G ratio of 1.40 and a beta of 0.40. The stock’s fifty day simple moving average is $775.43 and its two-hundred day simple moving average is $801.69. The company has a debt-to-equity ratio of 2.00, a quick ratio of 0.97 and a current ratio of 1.15.